Last reviewed · How we verify
NCT03935373
DNA Exome Sequencing TCM for Sjögren's Syndrome
trial testing DNA Exome sequencing in Sjögren's Syndrome in 40 participants. Status unknown.
15 May 2019
Quick facts
| Lead sponsor | Taipei Veterans General Hospital, Taiwan |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 40 |
| Start date | 1 April 2019 |
| Primary completion | 15 May 2019 |
| Estimated completion | 31 December 2019 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- DNA Exome sequencing
- Oral microbiome
- Proteomics
- RNA sequencing
- Cytokine — full drug profile →
- Traditional Chinese Medicine pattern
- Traditional Chinese Medicine tongue diagnosis
- Traditional Chinese Medicine pulse diagnosis
- Heart rate variability
- Schirmer's test
- Blood function test, liver function test, kidney function test, and immune function test
Conditions studied
- Sjögren's Syndrome — all drugs for Sjögren's Syndrome →
Sponsor
Taipei Veterans General Hospital, Taiwan
Who can join
Adults 20 to 75, any sex, with Sjögren's Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To explore the association among gene, TCM pattern, TCM tongue diagnosis and TCM pulse diagnosis with the DNA Exome sequencing tools for Sjögren's syndrome
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03935373
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of DNA Exome sequencing
Trials testing the same drug.
- NCT03938207 — Dry Eye Syndrome, Healthy Control, Sjögren's Syndrome and Other Inflammation Disease in Taiwan Biobank · not yet recruiting
Other recruiting trials for Sjögren's Syndrome
Currently open trials in the same condition.
- NCT06747949 — A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) · Phase 3 · recruiting
- NCT05946941 — A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome · Phase 3 · active not recruiting
Other Taipei Veterans General Hospital, Taiwan trials
Trials by the same sponsor.
- NCT07463443 — Effectiveness of Chatbot for Improving Caregiving Outcomes in Primary Caregivers of Geriatric Pneumonia Patients: A Stud · NA · not yet recruiting
- NCT07400757 — Statin and Vitamin D Treatment in Patients With Thyroid Eye Disease · NA · not yet recruiting
- NCT07362134 — Pulsed-Field Ablation for Recurrent Atypical Atrial Flutter · NA · enrolling by invitation
- NCT07473687 — Feasibility Study of Non-Contact Imaging-Based Physiological Monitoring in the Operating Room · recruiting
- NCT07344207 — GUARD-PH: Guided Use of AI-ECG for Risk Detection of PH in Surgery (GUARD-PH Trial) · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03935373 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Taipei Veterans General Hospital, Taiwan
- Last refreshed: 6 May 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03935373.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing